BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1
35 results:

  • 1. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
    Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
    Sci Rep; 2024 May; 14(1):10114. PubMed ID: 38698063
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells.
    Jhala D; Nathani N; Joshi M; Patel A; Joshi CG
    Oncol Res Treat; 2024; 47(1-2):10-17. PubMed ID: 38008084
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
    Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
    Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways.
    Yaslianifard S; Movahedi M; Yaslianifard S; Mozhgani SH
    BMC Res Notes; 2023 Jul; 16(1):147. PubMed ID: 37461070
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia.
    Cao L; Ruiz Buendía GA; Fournier N; Liu Y; Armand F; Hamelin R; Pavlou M; Radtke F
    Blood Adv; 2023 Oct; 7(20):6240-6252. PubMed ID: 37358480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
    Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
    BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
    Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
    Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.
    Cheon H; Xing JC; Moosic KB; Ung J; Chan VW; Chung DS; Toro MF; Elghawy O; Wang JS; Hamele CE; Hardison RC; Olson TL; Tan SF; Feith DJ; Ratan A; Loughran TP
    Blood; 2022 May; 139(20):3058-3072. PubMed ID: 35015834
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Construction of a microRNA-mRNA Regulatory Network in
    Esa E; Hashim AK; Mohamed EHM; Zakaria Z; Abu Hassan AN; Mat Yusoff Y; Kamaluddin NR; Abdul Rahman AZ; Chang KM; Mohamed R; Subbiah I; Jamian E; Ho CS; Lim SM; Lau PC; Pung YF; Zain SM
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):199-210. PubMed ID: 33734890
    [No Abstract]    [Full Text] [Related]  

  • 11. GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia.
    Zhou C; Du J; Zhao L; Liu W; Zhao T; Liang H; Fang P; Zhang K; Zeng H
    Cell Death Dis; 2021 Mar; 12(3):231. PubMed ID: 33658491
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and pik3r1.
    Belizaire R; Koochaki SHJ; Udeshi ND; Vedder A; Sun L; Svinkina T; Hartigan C; McConkey M; Kovalcik V; Bizuayehu A; Stanclift C; Schenone M; Carr SA; Padron E; Ebert BL
    Blood; 2021 Apr; 137(16):2209-2220. PubMed ID: 33512474
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
    Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
    Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.
    McNeer NA; Philip J; Geiger H; Ries RE; Lavallée VP; Walsh M; Shah M; Arora K; Emde AK; Robine N; Alonzo TA; Kolb EA; Gamis AS; Smith M; Gerhard DS; Guidry-Auvil J; Meshinchi S; Kentsis A
    Leukemia; 2019 Aug; 33(8):1934-1943. PubMed ID: 30760869
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Screening and verification of key genes in T-cell acute lymphoblastic leukemia].
    Jiang GJ; Chen YH; Guo W; Zhang H; Zou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):261-267. PubMed ID: 29643030
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.
    Wong RWJ; Ngoc PCT; Leong WZ; Yam AWY; Zhang T; Asamitsu K; Iida S; Okamoto T; Ueda R; Gray NS; Ishida T; Sanda T
    Blood; 2017 Nov; 130(21):2326-2338. PubMed ID: 28978570
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
    Liu Y; Easton J; Shao Y; Maciaszek J; Wang Z; Wilkinson MR; McCastlain K; Edmonson M; Pounds SB; Shi L; Zhou X; Ma X; Sioson E; Li Y; Rusch M; Gupta P; Pei D; Cheng C; Smith MA; Auvil JG; Gerhard DS; Relling MV; Winick NJ; Carroll AJ; Heerema NA; Raetz E; Devidas M; Willman CL; Harvey RC; Carroll WL; Dunsmore KP; Winter SS; Wood BL; Sorrentino BP; Downing JR; Loh ML; Hunger SP; Zhang J; Mullighan CG
    Nat Genet; 2017 Aug; 49(8):1211-1218. PubMed ID: 28671688
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092.
    Yu Y; Savage RE; Eathiraj S; Meade J; Wick MJ; Hall T; Abbadessa G; Schwartz B
    PLoS One; 2015; 10(10):e0140479. PubMed ID: 26469692
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
    Oliveira LH; Schiavinato JL; Fráguas MS; Lucena-Araujo AR; Haddad R; Araújo AG; Dalmazzo LF; Rego EM; Covas DT; Zago MA; Panepucci RA
    Cancer Sci; 2015 Oct; 106(10):1264-77. PubMed ID: 26251039
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Advances in basic and clinical immunology in 2014.
    Chinen J; Notarangelo LD; Shearer WT
    J Allergy Clin Immunol; 2015 May; 135(5):1132-41. PubMed ID: 25956014
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.